Biotech companies downsizing, blame a lack of capital funding
Without access to capital in Canada, companies will go elsewhere to commercialize the results of research funded by Canadian tax dollars, say biotech industry players.
Performance Plants Inc. was seen as the star of Kingston, Ont.-based budding knowledge-based economy.
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
